We represented Salveo Specialty Pharmacy in the completion of its Series A Preferred and senior subordinated debt financing and acquisition of Echo Specialty Pharmacy Services, a New York City metropolitan market pharmacy focused on transplant, oncology and HIV/AIDS therapies.

Salveo Specialty Pharmacy® is an independent specialty pharmacy company that provides a wide array of medications and clinical services to patients with chronic conditions and is backed by Three Arch Partners, NewSpring Capital, Petra Capital Partners and Sofinnova Ventures.